chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Dizziness, Lymphadenopathy, Rheumatoid arthritis, White blood cell count
Clinical narrative: Rheumatoid arthritis flare up; Dizziness; Increase white cell count; Swollen lymph nodes; blood pressure increased; This spontaneous case was reported by a physician and describes the occurrence of RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    Concurrent medical conditions included Chronic lymphocytic leukemia since 2018. Concomitant products included LISINOPRIL for Hypertension.   In January 2021, the patient started UPADACITINIB (RINVOQ) (Oral) 15 mg. In February 2021, UPADACITINIB (RINVOQ) (Oral) dosage was changed to 15 mg. In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) (seriousness criterion medically significant), DIZZINESS (Dizziness), WHITE BLOOD CELL COUNT INCREASED (Increase white cell count), BLOOD PRESSURE INCREASED and LYMPHADENOPATHY (Swollen lymph nodes). At the time of the report, RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) and WHITE BLOOD CELL COUNT INCREASED (Increase white cell count) had resolved, DIZZINESS (Dizziness) and BLOOD PRESSURE INCREASED outcome was unknown and LYMPHADENOPATHY (Swollen lymph nodes) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, White blood cell count: 3000 (Inconclusive) had gone down 3000. On an unknown date, White blood cell count: 3000 (High) was up 3000.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   treatment medication were not provided   This case was linked to MOD-2021-111543, MOD-2021-111543 (Patient Link).; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Rheumatoid arthritis flare up; Dizziness; Increase white cell count; Swollen lymph nodes; blood pressure increased; This spontaneous case was reported by a physician and describes the occurrence of RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    Concurrent medical conditions included Chronic lymphocytic leukemia since 2018. Concomitant products included LISINOPRIL for Hypertension.   In January 2021, the patient started UPADACITINIB (RINVOQ) (Oral) 15 mg. In February 2021, UPADACITINIB (RINVOQ) (Oral) dosage was changed to 15 mg. In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) (seriousness criterion medically significant), DIZZINESS (Dizziness), WHITE BLOOD CELL COUNT INCREASED (Increase white cell count), BLOOD PRESSURE INCREASED and LYMPHADENOPATHY (Swollen lymph nodes). At the time of the report, RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) and WHITE BLOOD CELL COUNT INCREASED (Increase white cell count) had resolved, DIZZINESS (Dizziness) and BLOOD PRESSURE INCREASED outcome was unknown and LYMPHADENOPATHY (Swollen lymph nodes) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, White blood cell count: 3000 (Inconclusive) had gone down 3000. On an unknown date, White blood cell count: 3000 (High) was up 3000.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   treatment medication were not provided   This case was linked to MOD-2021-111543, MOD-2021-111543 (Patient Link).; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Arthralgia, Back disorder, Neuralgia, Pain in extremity
Clinical narrative: Painful R arm; Back disorder; Nerve Pain; Arthritic Pains; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Painful R arm), BACK DISORDER (Back disorder), NEURALGIA (Nerve Pain) and ARTHRALGIA (Arthritic Pains) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for an unknown indication.    The patient's past medical history included Back disorder, Arthritic pains and Nerve pain.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and UPADACITINIB (RINVOQ) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (Painful R arm), BACK DISORDER (Back disorder), NEURALGIA (Nerve Pain) and ARTHRALGIA (Arthritic Pains). The patient was treated with Physical therapy for Pain in extremity; Physical therapy for Back disorder; Physical therapy for Neuralgia and Physical therapy for Arthralgia. At the time of the report, PAIN IN EXTREMITY (Painful R arm), BACK DISORDER (Back disorder), NEURALGIA (Nerve Pain) and ARTHRALGIA (Arthritic Pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product reported.  Treatment includes Physical therapy on 15-apr-2021.
Sex: M
Vaccine: COVID19, UNK
Symptoms: Incorrect dose administered, Pruritus, Rash papular, Vaccination site pain, Wrong technique in product usage process
Clinical narrative: Wron technique; Rash Papular; Itching; vaccination site pain; Incomplete dose administered; This spontaneous case was reported by a physician and describes the occurrence of INCORRECT DOSE ADMINISTERED (Incomplete dose administered), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Wron technique), RASH PAPULAR (Rash Papular), PRURITUS (Itching) and VACCINATION SITE PAIN (vaccination site pain) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ankylosing spondylitis.    No Medical History information was reported.   In 2019, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg/dl. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Incomplete dose administered). On an unknown date, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Wron technique), RASH PAPULAR (Rash Papular), PRURITUS (Itching) and VACCINATION SITE PAIN (vaccination site pain). At the time of the report, INCORRECT DOSE ADMINISTERED (Incomplete dose administered), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Wron technique), RASH PAPULAR (Rash Papular), PRURITUS (Itching) and VACCINATION SITE PAIN (vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medications were reported,.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Inappropriate schedule of product administration; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis.   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment was reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and ADALIMUMAB (HUMIRA) (unknown route) 1 dosage form. and ADALIMUMAB (HUMIRA) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm). At the time of the report, PAIN IN EXTREMITY (Pain in arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Oral herpes, Pain, Paraesthesia oral
Clinical narrative: Pain; Cold sore; Swelling of lip; Tingling to bottom lip; This spontaneous case was reported by a health care professional and describes the occurrence of LIP SWELLING (Swelling of lip), PARAESTHESIA ORAL (Tingling to bottom lip), PAIN (Pain) and ORAL HERPES (Cold sore) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by the reporter.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 22-Apr-2021, the patient experienced LIP SWELLING (Swelling of lip), PARAESTHESIA ORAL (Tingling to bottom lip) and ORAL HERPES (Cold sore). On an unknown date, the patient experienced PAIN (Pain). The patient was treated with VALACYCLOVIR [VALACICLOVIR] at a dose of 2000 milligram X 2 doses. At the time of the report, LIP SWELLING (Swelling of lip), PARAESTHESIA ORAL (Tingling to bottom lip), PAIN (Pain) and ORAL HERPES (Cold sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   patient had restylane kysse  (lip filler) injected to the lips on 26 march 2021.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test abnormal
Clinical narrative: Blood test Abnormal; This spontaneous case was reported by a physician and describes the occurrence of BLOOD TEST ABNORMAL (Blood test Abnormal) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD TEST ABNORMAL (Blood test Abnormal). At the time of the report, BLOOD TEST ABNORMAL (Blood test Abnormal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   RINVOQ used as Suspect drug.  No concomitant medications reported by investigator.  No treatment medications provided by the reporter.   This case was linked to MOD-2021-113630 (Patient Link).
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104 (High) lasted 24-48 hours.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details were provided. No treatment medication details were provided.   This case was linked to MOD-2021-113578 (Patient Link).
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104 (High) lasted 24-48 hrs.         No treatment and concomitant medications were reported   This case was linked to MOD-2021-113560 (Patient Link).
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site bruising
Clinical narrative: Injection site bruising; This spontaneous case was reported by a physician and describes the occurrence of INJECTION SITE BRUISING (Injection site bruising) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Colitis ulcerative.    No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE BRUISING (Injection site bruising). At the time of the report, INJECTION SITE BRUISING (Injection site bruising) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication history was not provided.  Treatment information was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            No treatment was provided by the reporter.
Age: 56.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Blood test, Blood test abnormal
Clinical narrative: Blood test abnormal; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of BLOOD TEST ABNORMAL (Blood test abnormal) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    No medical history was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On an unknown date, the patient experienced BLOOD TEST ABNORMAL (Blood test abnormal). At the time of the report, BLOOD TEST ABNORMAL (Blood test abnormal) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood test: elevated (High) inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment information was reported.   This case was linked to MOD-2021-113543 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Skin exfoliation
Clinical narrative: Skin became itchy; skin became itchy and scaly all; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Skin became itchy) and SKIN EXFOLIATION (skin became itchy and scaly all) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Skin became itchy) and SKIN EXFOLIATION (skin became itchy and scaly all). At the time of the report, PRURITUS (Skin became itchy) and SKIN EXFOLIATION (skin became itchy and scaly all) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: body aches; Joint Pain; This spontaneous case was reported by a physician and describes the occurrence of PAIN (body aches) and ARTHRALGIA (Joint Pain) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PAIN (body aches) and ARTHRALGIA (Joint Pain). At the time of the report, PAIN (body aches) and ARTHRALGIA (Joint Pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details were provided. No treatment medication details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Night sweats, Pyrexia
Clinical narrative: night sweats; fatigue; low grade fever; This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (low grade fever), NIGHT SWEATS (night sweats) and FATIGUE (fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On 08-Mar-2021, the patient experienced PYREXIA (low grade fever). On 16-Apr-2021, the patient experienced FATIGUE (fatigue). On an unknown date, the patient experienced NIGHT SWEATS (night sweats). On 08-Mar-2021, PYREXIA (low grade fever) had resolved. At the time of the report, NIGHT SWEATS (night sweats) had not resolved and FATIGUE (fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treated with IBUPROFEN.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Little tired; their arm hurts only when they touch it.; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FATIGUE (Little tired) and VACCINATION SITE PAIN (their arm hurts only when they touch it.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Heart disorder. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 15-Mar-2021 at 1:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced FATIGUE (Little tired) and VACCINATION SITE PAIN (their arm hurts only when they touch it.). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, FATIGUE (Little tired) and VACCINATION SITE PAIN (their arm hurts only when they touch it.) had resolved.            Acetaminophen is used as treatment medication.  Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-046229 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow-up received on 06-MAY-2021. Consumer informed that she is recovered from all the AEs and declined further follow up
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness in bilateral hands; tingling sensation; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in bilateral hands) and PARAESTHESIA (tingling sensation) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     Concurrent medical conditions included Latex allergy.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness in bilateral hands) and PARAESTHESIA (tingling sensation). At the time of the report, HYPOAESTHESIA (Numbness in bilateral hands) and PARAESTHESIA (tingling sensation) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: hands, arms, lower knee is still itching, scalp too; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (hands, arms, lower knee is still itching, scalp too) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced PRURITUS (hands, arms, lower knee is still itching, scalp too). The patient was treated with ACRIVASTINE (BENADRYL [ACRIVASTINE]) at a dose of 25 mg. At the time of the report, PRURITUS (hands, arms, lower knee is still itching, scalp too) outcome was unknown. Not Provided          treatment medication include steroid shot
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain in extremity
Clinical narrative: mildly sore arm; chills; extreme headache; extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (mildly sore arm), CHILLS (chills), HEADACHE (extreme headache) and FATIGUE (extremely tired) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PAIN IN EXTREMITY (mildly sore arm), CHILLS (chills), HEADACHE (extreme headache) and FATIGUE (extremely tired). On 18-Apr-2021, PAIN IN EXTREMITY (mildly sore arm) and FATIGUE (extremely tired) had resolved. On 20-Apr-2021, CHILLS (chills) and HEADACHE (extreme headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medication reported includes Aleve.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lupus erythematosus.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms) outcome was unknown.            No concomitant medications were reported.  No treatment information for the events was provided.   Reporter did not allow further contact
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Skin lesion
Clinical narrative: Lesions like mosquito or flea bites on breast, back and stomach; Feeling tired; Pain on joints (left hand); This spontaneous case was reported by a consumer and describes the occurrence of SKIN LESION (Lesions like mosquito or flea bites on breast, back and stomach), FATIGUE (Feeling tired) and ARTHRALGIA (Pain on joints (left hand)) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     The patient's past medical history included Joint pain and Shingles in October 2020. Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN and IBUPROFEN (ADVIL 12 HOUR) for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced FATIGUE (Feeling tired) and ARTHRALGIA (Pain on joints (left hand)). On 07-May-2021, the patient experienced SKIN LESION (Lesions like mosquito or flea bites on breast, back and stomach). At the time of the report, SKIN LESION (Lesions like mosquito or flea bites on breast, back and stomach), FATIGUE (Feeling tired) and ARTHRALGIA (Pain on joints (left hand)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment given included cream containing Cortisone.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Myalgia, Taste disorder
Clinical narrative: Sense of taste changed; Swollen lymph node (size of a golf ball); Painful lymph node; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of LYMPH NODE PAIN (Painful lymph node), TASTE DISORDER (Sense of taste changed), LYMPHADENOPATHY (Swollen lymph node (size of a golf ball)) and MYALGIA (Soreness) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE, QUETIAPINE FUMARATE (SEROQUEL), VALPROATE SEMISODIUM (DEPAKOTE), PRAVASTATIN, FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and ALBUTEROL [SALBUTAMOL] for an unknown indication.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced MYALGIA (Soreness). On 05-May-2021, the patient experienced LYMPH NODE PAIN (Painful lymph node) and LYMPHADENOPATHY (Swollen lymph node (size of a golf ball)). On 08-May-2021, the patient experienced TASTE DISORDER (Sense of taste changed). At the time of the report, LYMPH NODE PAIN (Painful lymph node), TASTE DISORDER (Sense of taste changed), LYMPHADENOPATHY (Swollen lymph node (size of a golf ball)) and MYALGIA (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information included Tylenol.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: really intense pain in arm; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (really intense pain in arm), PYREXIA (fever) and CHILLS (chills) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included TRETINOIN and CLINDAMYCIN for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (really intense pain in arm), PYREXIA (fever) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (really intense pain in arm), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medication include Tarina Birth Control
Sex: U
Vaccine: COVID19
Symptoms: Rash erythematous, Vaccination site pain
Clinical narrative: Painful hot purple red arm; Painful hot purple red arm from injection site to just above elbow and 50% of width of arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Painful hot purple red arm ) and VACCINATION SITE PAIN (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Painful hot purple red arm ) and VACCINATION SITE PAIN (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm). At the time of the report, RASH ERYTHEMATOUS (Painful hot purple red arm ) and VACCINATION SITE PAIN (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) had resolved.            No concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD-2021-114185 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Not as warm but more itching; tiredness; headache; my pink swollen area around the injection site was back and Again about the size of a 4 x 4 pad; my pink swollen area around the injection site was back and Again about the size of a 4 x 4 pad; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Not as warm but more itching), VACCINATION SITE SWELLING (my pink swollen area around the injection site was back and Again about the size of a 4 x 4 pad), VACCINATION SITE ERYTHEMA (my pink swollen area around the injection site was back and Again about the size of a 4 x 4 pad), FATIGUE (tiredness) and HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Blood pressure high since an unknown date. Concomitant products included LOSARTAN and HCTZ for Blood pressure abnormal, CALCIUM CITRATE, COLECALCIFEROL (CITRACAL + D [CALCIUM CITRATE;COLECALCIFEROL]) for Bone disorder (NOS), POTASSIUM for Low potassium therapeutic diet, PRAVASTATIN SODIUM, CARVEDILOL, IRON and AMLODIPINE for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 12-Mar-2021, the patient experienced VACCINATION SITE SWELLING (my pink swollen area around the injection site was back and Again about the size of a 4 x 4 pad) and VACCINATION SITE ERYTHEMA (my pink swollen area around the injection site was back and Again about the size of a 4 x 4 pad). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Not as warm but more itching). an unknown date, the patient experienced FATIGUE (tiredness) and HEADACHE (headache). The patient was treated with mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Not as warm but more itching), VACCINATION SITE SWELLING (my pink swollen area around the injection site was back and Again about the size of a 4 x 4 pad), VACCINATION SITE ERYTHEMA (my pink swollen area around the injection site was back and Again about the size of a 4 x 4 pad), FATIGUE (tiredness) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication included centrum silver qd by mouth for age.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Chills, Myalgia, Pain
Clinical narrative: stomach pain; top of shoulder aches the radiates up to the neck like toothache; Chills; Fever; muscles hurts all over; joints hurts all over; muscle soreness in the arm at vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), PAIN (top of shoulder aches the radiates up to the neck like toothache), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (muscles hurts all over) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), PAIN (top of shoulder aches the radiates up to the neck like toothache), CHILLS (Chills), PYREXIA (Fever), MYALGIA (muscles hurts all over), ARTHRALGIA (joints hurts all over) and VACCINATION SITE PAIN (muscle soreness in the arm at vaccination site). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), PAIN (top of shoulder aches the radiates up to the neck like toothache), CHILLS (Chills), PYREXIA (Fever), MYALGIA (muscles hurts all over), ARTHRALGIA (joints hurts all over) and VACCINATION SITE PAIN (muscle soreness in the arm at vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: stomach pain; top of shoulder aches the radiates up to the neck like toothache; Chills; Fever; muscles hurts all over; joints hurts all over; muscle soreness in the arm at vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), PAIN (top of shoulder aches the radiates up to the neck like toothache), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (muscles hurts all over) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), PAIN (top of shoulder aches the radiates up to the neck like toothache), CHILLS (Chills), PYREXIA (Fever), MYALGIA (muscles hurts all over), ARTHRALGIA (joints hurts all over) and VACCINATION SITE PAIN (muscle soreness in the arm at vaccination site). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), PAIN (top of shoulder aches the radiates up to the neck like toothache), CHILLS (Chills), PYREXIA (Fever), MYALGIA (muscles hurts all over), ARTHRALGIA (joints hurts all over) and VACCINATION SITE PAIN (muscle soreness in the arm at vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Hypoaesthesia, Illness, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in hands/numbness in his both hand fingers for last couple weeks), PAIN IN EXTREMITY (Left arm drastically hurting), ILLNESS (still sick), CHILLS (Chills) and MYALGIA (Muscle aches and pain) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced HYPOAESTHESIA (Numbness in hands/numbness in his both hand fingers for last couple weeks), PAIN IN EXTREMITY (Left arm drastically hurting) and CHILLS (Chills). On an unknown date, the patient experienced ILLNESS (still sick), MYALGIA (Muscle aches and pain) and PYREXIA (fever of 104.1/High fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. On 26-Apr-2021, CHILLS (Chills) had resolved. At the time of the report, HYPOAESTHESIA (Numbness in hands/numbness in his both hand fingers for last couple weeks), PAIN IN EXTREMITY (Left arm drastically hurting) and MYALGIA (Muscle aches and pain) outcome was unknown and ILLNESS (still sick) and PYREXIA (fever of 104.1/High fever) had not resolved.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.1 (High) body temperature -104.1 (High fever). For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided. Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up information received on 08-JUN-2021contains significant information- new event-sick added, lab data fever 104.1 added, contact information updated. On 21-Jul-2021: Follow up received contains: Updated patient information- Height, Weight, Race, Ethnicity; Updated event- Muscle aches and pain; Updated event outcomes- events are ongoing and recurring.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in hands/numbness in his both hand fingers for last couple weeks), PAIN IN EXTREMITY (Left arm drastically hurting), ILLNESS (still sick), CHILLS (Chills) and MYALGIA (Muscle aches and pain) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced HYPOAESTHESIA (Numbness in hands/numbness in his both hand fingers for last couple weeks), PAIN IN EXTREMITY (Left arm drastically hurting) and CHILLS (Chills). On an unknown date, the patient experienced ILLNESS (still sick), MYALGIA (Muscle aches and pain) and PYREXIA (fever of 104.1/High fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. On 26-Apr-2021, CHILLS (Chills) had resolved. At the time of the report, HYPOAESTHESIA (Numbness in hands/numbness in his both hand fingers for last couple weeks), PAIN IN EXTREMITY (Left arm drastically hurting) and MYALGIA (Muscle aches and pain) outcome was unknown and ILLNESS (still sick) and PYREXIA (fever of 104.1/High fever) had not resolved.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.1 (High) body temperature -104.1 (High fever). For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided. Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up information received on 08-JUN-2021contains significant information- new event-sick added, lab data fever 104.1 added, contact information updated. On 21-Jul-2021: Follow up received contains: Updated patient information- Height, Weight, Race, Ethnicity; Updated event- Muscle aches and pain; Updated event outcomes- events are ongoing and recurring.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, Peripheral swelling
Clinical narrative: arm got swollen; arm is still hurting, she can barely lift her arm; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm got swollen), PAIN IN EXTREMITY (arm is still hurting, she can barely lift her arm) and ARTHRALGIA (Joint pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PERIPHERAL SWELLING (arm got swollen), PAIN IN EXTREMITY (arm is still hurting, she can barely lift her arm) and ARTHRALGIA (Joint pain). At the time of the report, PERIPHERAL SWELLING (arm got swollen), PAIN IN EXTREMITY (arm is still hurting, she can barely lift her arm) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Chills, Headache, Nausea, Pyrexia
Clinical narrative: spot on the back of her head a little bigger than golf ball where her hair is missing hair and all bald.; headache; nausea; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (spot on the back of her head a little bigger than golf ball where her hair is missing hair and all bald.), HEADACHE (headache), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (TARINA FE), TRETINOIN and CLINDAMYCIN for an unknown indication.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (spot on the back of her head a little bigger than golf ball where her hair is missing hair and all bald.), HEADACHE (headache), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, ALOPECIA (spot on the back of her head a little bigger than golf ball where her hair is missing hair and all bald.), HEADACHE (headache), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details include Ibuprofen